What does DR. STEVEN VERCAUTEREN do?

DR. STEVEN VERCAUTEREN is a specialist medical practice in Overijse. Private Limited, started on 12 February 2007.

What is the address of DR. STEVEN VERCAUTEREN?

The registered office of DR. STEVEN VERCAUTEREN is located at Genvalstraat 112, 3090 Overijse.

Is DR. STEVEN VERCAUTEREN still active?

Yes. According to the CBE (19 September 2026) DR. STEVEN VERCAUTEREN is active, legal situation “Normale toestand”, started on 12 February 2007.

Is DR. STEVEN VERCAUTEREN registered on Peppol?

Yes, DR. STEVEN VERCAUTEREN is registered on the Peppol network with ID 0208:0887167938.

What is the enterprise number of DR. STEVEN VERCAUTEREN?

The enterprise number of DR. STEVEN VERCAUTEREN is BE0887167938.

When was DR. STEVEN VERCAUTEREN founded?

DR. STEVEN VERCAUTEREN was founded on 12 February 2007.

Who are the directors of DR. STEVEN VERCAUTEREN?

According to the 2025 annual accounts, the directors of DR. STEVEN VERCAUTEREN are: Steven VERCAUTEREN.

Is DR. STEVEN VERCAUTEREN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 February 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. STEVEN VERCAUTEREN make in 2025?

DR. STEVEN VERCAUTEREN posted a profit after taxes of € 143,076 in financial year 2025.

What is the revenue of DR. STEVEN VERCAUTEREN?

As a small company, DR. STEVEN VERCAUTEREN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 203,289.

DR. STEVEN VERCAUTEREN (Private Limited) - Overijse

Dossier DR. STEVEN VERCAUTEREN, printed on 19 September 2026 from databakkes.be/en/0887167938/dr-steven-vercauteren. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. STEVEN VERCAUTEREN from Overijse, company number BE0887167938, closed financial year 2025 with a result of € 143,076 after tax. For that financial year DR. STEVEN VERCAUTEREN recorded a gross margin of € 203,289 and equity of € 658,312. Compared with financial year 2024, the result moved from € 142,919 to € 143,076. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 11, 2026.

What it is worth Healthy

€ 658,312

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 143,076

Profit after tax over the fiscal year.

Cash in the bank

€ 562,530

▲ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 172,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 30,611

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 308

▼ 88% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,150

▼ 26% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 177,008 Gross margin 2022: € 177,008 First fiscal year in the series	€ 208,678 Gross margin 2023: € 208,678 ▲ 18% vs 2022 (€ 177,008) Favourable step	€ 212,555 Gross margin 2024: € 212,555 ▲ 2% vs 2023 (€ 208,678) Favourable step	€ 203,289 Gross margin 2025: € 203,289 ▼ 4% vs 2024 (€ 212,555) Unfavourable step	▼ 4%
Profit after taxes	€ 112,707 Profit after taxes 2022: € 112,707 First fiscal year in the series	€ 131,975 Profit after taxes 2023: € 131,975 ▲ 17% vs 2022 (€ 112,707) Favourable step	€ 142,919 Profit after taxes 2024: € 142,919 ▲ 8% vs 2023 (€ 131,975) Favourable step	€ 143,076 Profit after taxes 2025: € 143,076 Unchanged (€ 142,919) Favourable step
Equity	€ 658,241 Equity 2022: € 658,241 First fiscal year in the series	€ 655,816 Equity 2023: € 655,816 Unchanged (€ 658,241) Unfavourable step	€ 687,236 Equity 2024: € 687,236 ▲ 5% vs 2023 (€ 655,816) Favourable step	€ 658,312 Equity 2025: € 658,312 ▼ 4% vs 2024 (€ 687,236) Unfavourable step	▼ 4%
Total debts	€ 32,950 Total debts 2022: € 32,950 First fiscal year in the series	€ 19,635 Total debts 2023: € 19,635 ▼ 40% vs 2022 (€ 32,950) Favourable step	€ 26,943 Total debts 2024: € 26,943 ▲ 37% vs 2023 (€ 19,635) Unfavourable step	€ 95,040 Total debts 2025: € 95,040 ▲ 253% vs 2024 (€ 26,943) Unfavourable step	▲ 253%
Cash	€ 512,396 Cash 2022: € 512,396 First fiscal year in the series	€ 495,388 Cash 2023: € 495,388 ▼ 3% vs 2022 (€ 512,396) Unfavourable step	€ 517,052 Cash 2024: € 517,052 ▲ 4% vs 2023 (€ 495,388) Favourable step	€ 562,530 Cash 2025: € 562,530 ▲ 9% vs 2024 (€ 517,052) Favourable step	▲ 9%
Land & buildings	€ 613 Land & buildings 2022: € 613 First fiscal year in the series	-	-	-
Retained profit	€ 645,841 Retained profit 2022: € 645,841 First fiscal year in the series	€ 626,512 Retained profit 2023: € 626,512 ▼ 3% vs 2022 (€ 645,841) Unfavourable step	€ 657,931 Retained profit 2024: € 657,931 ▲ 5% vs 2023 (€ 626,512) Favourable step	€ 629,007 Retained profit 2025: € 629,007 ▼ 4% vs 2024 (€ 657,931) Unfavourable step	▼ 4%
Dividend	€ 73,000 Dividend 2022: € 73,000 First fiscal year in the series	€ 134,400 Dividend 2023: € 134,400 ▲ 84% vs 2022 (€ 73,000) Unchanged	€ 111,500 Dividend 2024: € 111,500 ▼ 17% vs 2023 (€ 134,400) Unchanged	€ 172,000 Dividend 2025: € 172,000 ▲ 54% vs 2024 (€ 111,500) Unchanged	▲ 54%
Balance sheet total	€ 691,192 Balance sheet total 2022: € 691,192 First fiscal year in the series	€ 675,452 Balance sheet total 2023: € 675,452 ▼ 2% vs 2022 (€ 691,192) Unchanged	€ 714,179 Balance sheet total 2024: € 714,179 ▲ 6% vs 2023 (€ 675,452) Unchanged	€ 753,352 Balance sheet total 2025: € 753,352 ▲ 5% vs 2024 (€ 714,179) Unchanged	▲ 5%

Key figures of DR. STEVEN VERCAUTEREN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. STEVEN VERCAUTEREN?

What happened at DR. STEVEN VERCAUTEREN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 11, 2026 New annual accounts for financial year 2025: profit of € 143,076. Source: NBB ↗
Feb 12, 2007 Start of the company according to the CBE. KBO

In short

From € 112,707 profit in 2022 to € 143,076 profit in 2025.

Paid € 213,899 in corporate taxes since 2022.

Best year ever: 2025, with € 143,076 profit.

Paid out € 490,900 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. STEVEN VERCAUTEREN? We notify you, reason included.

Follow DR. STEVEN VERCAUTEREN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Steven VERCAUTEREN

DR. STEVEN VERCAUTEREN

Behind DR. STEVEN VERCAUTEREN is Steven VERCAUTEREN.

See the full network in the app

Directors

According to the 2025 annual accounts

Steven VERCAUTEREN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Genvalstraat 112

3090 Overijse

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0887.167.938

VAT number

BE 0887.167.938

Registered office

Genvalstraat 112, 3090 Overijse

Names & denominations

DR. STEVEN VERCAUTEREN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 February 2007

Peppol

Active · Active since 22 Dec 2025

Activities · NACE

Activiteiten van medisch specialisten

Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. STEVEN VERCAUTEREN

Financials

What happened to DR. STEVEN VERCAUTEREN?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions